New imaging and measurement technology may help vascular surgeons predict the risk of potentially fatal ruptures in patients with abdominal aortic aneurysms. Medical Metrx Solutions, a leading provider of 3D medical imaging and metrics, is providing
New imaging and measurement technology may help vascular surgeons predict the risk of potentially fatal ruptures in patients with abdominal aortic aneurysms. Medical Metrx Solutions, a leading provider of 3D medical imaging and metrics, is providing technology for use in a multicenter clinical study to evaluate the rupture risk of AAAs. Reliable assessment of rupture risk in patients is important to reduce aneurysm-related mortality while avoiding unnecessary surgery. The company's optimized 3D reconstruction and finite element analysis technology generate patient-specific stress maps that illustrate aortic aneurysm wall stress. Metrx is also providing core lab services for the clinical trial through its data communication infrastructure, allowing participants to enter study data online.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.